Clare Market Investments LLC Buys New Shares in Corteva, Inc. $CTVA

Clare Market Investments LLC purchased a new position in shares of Corteva, Inc. (NYSE:CTVA) in the 1st quarter, Holdings Channel reports. The firm purchased 7,450 shares of the company’s stock, valued at approximately $624,000.

A number of other hedge funds also recently made changes to their positions in CTVA. JPL Wealth Management LLC purchased a new stake in shares of Corteva during the 3rd quarter valued at $25,000. Garton & Associates Financial Advisors LLC purchased a new position in shares of Corteva in the 4th quarter worth $27,000. Bank of Jackson Hole Trust acquired a new position in Corteva in the fourth quarter valued at $28,000. Cornerstone Financial Management LLC acquired a new position in Corteva in the fourth quarter valued at $29,000. Finally, Basepoint Wealth LLC purchased a new stake in Corteva during the fourth quarter valued at about $30,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Ratings Changes

CTVA has been the subject of several research analyst reports. Berenberg Bank upped their price target on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research note on Thursday, March 26th. Morgan Stanley boosted their target price on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Jefferies Financial Group raised their price target on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Barclays boosted their price objective on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Finally, Mizuho raised their target price on Corteva from $94.00 to $96.00 and gave the company an “outperform” rating in a research note on Thursday, July 2nd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and a consensus target price of $88.90.

Corteva Stock Up 1.1%

Shares of Corteva stock opened at $87.34 on Tuesday. The business has a 50-day moving average price of $79.80 and a 200 day moving average price of $76.94. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $87.18. The firm has a market cap of $58.41 billion, a P/E ratio of 51.35, a P/E/G ratio of 2.62 and a beta of 0.56. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the previous year, the business earned $1.13 EPS. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s dividend payout ratio is currently 42.35%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.